< Back to news
Dr. Carlos Moreno Yruela, new leader of IBEC's Enzymatic Sensors and Chemical Probes research group. Foto / IBEC
 17.09.2026

Carlos Moreno Yruela, new leader of IBEC’s Enzymatic Sensors and Chemical Probes research group

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park (PCB-UB), welcomes Dr. Carlos Moreno Yruela as principal junior investigator of the Enzyme Sensors and Chemical Probes group. Coming from the Swiss Federal Institute of Technology in Lausanne (EPFL, Switzerland), Moreno-Yruela was recently awarded an ERC Starting Grant from the European Research Council (ERC) to develop the CHEMTUBIO project.

The aim of Carlos Moreno-Yruela’s will be to develop chemical probes and imaging tools that help us understand the mechanisms of disease, laying the groundwork for future drug-discovery methods. The team focuses on enzymes — proteins that act as cellular “switches” by adding or removing small chemical marks on other proteins, known as post-translational modifications — which, depending on how they are switched on or off, can either drive or slow the progress of a disease.

The group is also developing sensors that, once inserted into the proteins themselves, make it possible to observe enzyme activity inside living cells in real time. This allows disease-causing enzymes to be pinpointed with great precision, and in turn supports the development of platforms able to identify, among thousands of candidate molecules, those with the greatest potential to become an effective drug against them. This is basic research aimed at laying the groundwork for potential future therapies for heart disease, nervous-system repair and cancer.

“IBEC’s interdisciplinary structure, together with its extensive experience in developing disease models and advanced therapies, will help our research have greater impact,” says Moreno.

CHEMTUBIO project

At IBEC, Moreno-Yruela will carry out the CHEMTUBIO project, selected under the ERC Starting Grant call, which focuses on the chemistry of the enzymes that “erase” modifications on microtubules, a key component of the cell’s skeleton. These enzymes are essential to how our cells function and have shown promising potential as therapeutic targets for treating cancer, as well as heart and neurological diseases.

» Link to the news: IBEC website [+]